河北医科大学学报
河北醫科大學學報
하북의과대학학보
JOURNAL OF HEBEI MEDICAL UNIVERSITY
2001年
2期
78-79
,共2页
红细胞生成素/类似物和衍生物%贫血%肾疾病/并发症
紅細胞生成素/類似物和衍生物%貧血%腎疾病/併髮癥
홍세포생성소/유사물화연생물%빈혈%신질병/병발증
目的比较宁红欣(国产红细胞生成素)和利血宝治疗肾性贫血的临床疗效。方法选择肾性贫血120例,随机分为宁红欣(2000U,皮下注射,每周3次)治疗组60例和利血宝(3000U,皮下注射,每周2次)对照组60例,均治疗12周。结果与治疗前比较,宁红欣总有效率86.7 %,显效率55.0 %。利血宝总有效率85.0 %,显效率50.0 %。两组间上述参数在治疗前、治疗后4、8、12周均无统计学差异(P>0.05)。结论宁红欣治疗肾性贫血与利血宝疗效基本相当。
目的比較寧紅訢(國產紅細胞生成素)和利血寶治療腎性貧血的臨床療效。方法選擇腎性貧血120例,隨機分為寧紅訢(2000U,皮下註射,每週3次)治療組60例和利血寶(3000U,皮下註射,每週2次)對照組60例,均治療12週。結果與治療前比較,寧紅訢總有效率86.7 %,顯效率55.0 %。利血寶總有效率85.0 %,顯效率50.0 %。兩組間上述參數在治療前、治療後4、8、12週均無統計學差異(P>0.05)。結論寧紅訢治療腎性貧血與利血寶療效基本相噹。
목적비교저홍흔(국산홍세포생성소)화리혈보치료신성빈혈적림상료효。방법선택신성빈혈120례,수궤분위저홍흔(2000U,피하주사,매주3차)치료조60례화리혈보(3000U,피하주사,매주2차)대조조60례,균치료12주。결과여치료전비교,저홍흔총유효솔86.7 %,현효솔55.0 %。리혈보총유효솔85.0 %,현효솔50.0 %。량조간상술삼수재치료전、치료후4、8、12주균무통계학차이(P>0.05)。결론저홍흔치료신성빈혈여리혈보료효기본상당。
Objective To compare the efficacy of Ninghongxin(a kind of domestic rhu-EPO) and Lixuebao in treatment of renal anemia.Methods 120 patients with renal anemia were randomly divided to receive Ninghongxin (n=60) in a dose of 2000U,three times every week for 12 weeks, and Lixuebao (n=60) in a dose of 3000U,twice every week for 12 weeks.Results After treatment, the total effective rate of Ninghongxin was 86.7 %,the effective rate was 55 %.The total effective rate of Lixuebao was 85 %, the effective rate was 50 %.There is no significant difference between all parameters of the two groups.Conclusion The study showed that the efficacy of Ninghongxin in the treatment of renal anemia is as effective as those of Lixuebao in doses stated above.